Mimotopes of cytolytic T lymphocytes in cancer immunotherapy (Q30697868)

26 June 2017

1 reference

title

Mimotopes of cytolytic T lymphocytes in cancer immunotherapy (English)

1 reference

26 June 2017

0 references

1 reference

Chen L

1

1 reference

26 June 2017

1 April 1999

1 reference

Current Opinion in Immunology

26 June 2017

1 reference

26 June 2017

11

1 reference

26 June 2017

2

1 reference

26 June 2017

219-222

1 reference

Genetic instabilities in human cancers

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Non-traditionally derived CTL epitopes: exceptions that prove the rules?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Cancer Tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Cancer vaccines based on the identification of genes encoding cancer regression antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Antigen recognition. Class discrimination in the world of immunology

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Cross-presentation: a general mechanism for CTL immunity and tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Immunological ignorance of silent antigens as an explanation of tumor evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Identification of peptides for immunotherapy of cancer. It is worth the effort.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Direct identification of tumor-associated peptide antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

T-cell epitope determination

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Probing degeneracy in T-cell recognition using peptide combinatorial libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Identification of mimotopes for the H4 minor histocompatibility antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

An H-YDb epitope is encoded by a novel mouse Y chromosome gene

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Allo- and self-restricted cytotoxic T lymphocytes against a peptide library: evidence for a functionally diverse allorestricted T cell repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980037-5

7 January 2021

10.1016/S0952-7915(99)80037-5

Identifiers

DOI

1 reference

26 June 2017

1 reference

PubMed ID

10322156